PAPHOS, Cyprus, Feb. 11, 2025 — ILIKOS Consulting Group and the Jordan Center for Pharmaceutical Research (JCPR) have formed a strategic partnership to showcase the benefits of designing and conducting BE/BA studies in Jordan, thereby advancing innovative clinical research nationwide.

Partnership Objectives:

• Highlight the advantages of performing BA/BE clinical trials in Jordan.
• Expand patient access to promising new treatments.

Given the extended timelines and heightened risks in developing new therapies and technologies, exploring emerging regions that offer high-quality, cost-effective services and efficient recruitment is crucial. The generics industry faces numerous cross-regional challenges, including evolving regulations, data standardization needs, and cost pressures.

“With the generics industry facing increasing global pressures—from regulatory changes to rising development costs—innovative and dependable solutions are essential,” stated Mr. Elias Sayias, Founder and CEO of ILIKOS. “Jordan’s strategic location, combined with JCPR’s extensive expertise, presents a compelling value proposition for Sponsors tackling the complexities of modern drug development. Our aim is to bridge cultural, regulatory, and operational gaps to deliver cost-effective, high-quality results.”

JCPR, a leading generics research center with decades of experience, provides generics manufacturers with a comprehensive solution to overcome development obstacles and operational challenges. The center excels in navigating regulatory frameworks, ensuring data standardization, and offering exceptional recruitment capabilities across the region.

JCPR is the first established and accredited Clinical Research Organization (CRO) in Amman, Jordan. It holds accreditations from the JFDA, GCC, and EMA, and enjoys a strong reputation across the MENA, USA, Asia, and North African regions.

“The Jordan Center for Pharmaceutical Research (JCPR) has been a cornerstone of clinical research excellence in the MENA region for over two decades. As a leading institution in BA/BE studies for the generics industry, JCPR is proud to be EMA-inspected and accredited by numerous regulatory bodies. We are also pleased to have expanded our presence to Europe and to have established a strong presence in first-in-human studies, medical device testing, and clinical trials. Our services now support global partners, including those taking initial steps to enter the U.S. market. With a firm commitment to high-quality, regulatory-compliant research, innovation, and precision, JCPR remains a trusted partner in advancing safe and effective medicines and medical devices,” noted Eng. Tareq T. Arafat, Head of Business Development at JCPR.

About ILIKOS Consulting Group

ILIKOS Consulting Group provides adaptable and highly customized services to Contract Research Organizations (CROs) and life science companies. It specializes in developing and implementing effective commercial and business development strategies, addressing challenges related to cost, quality, consistency, and market alignment.

To learn more, visit:

For inquiries, please contact:
Elias Sayias, BSc. CCRA

Founder & CEO
Email:

About Jordan Center for Pharmaceutical Research (JCPR)

JCPR is a leading pharmaceutical research center in Jordan specializing in clinical trial execution, regulatory compliance, and innovation. The center offers Sponsors access to advanced medical expertise, proven operational capabilities, and dependable patient recruitment solutions across the region.

JCPR has completed over 900 bioequivalence studies:

• Encompassing all aspects of clinical study design and execution, from regulatory affairs and protocol design to PK and statistical analysis using SAS and Winnonlin.
• Featuring rapid timelines—achieving JFDA approval within two weeks of contract signing, with dosing commencing within ten days of JFDA approval.
• Utilizing two state-of-the-art clinical sites with over 120 beds, supported by advanced bioanalytical facilities equipped with LCMS-MS platforms to ensure precision and reliability.

For more information, visit:

For inquiries, please contact:
Eng. Tareq Arafat
Business Development Manager
Email:  

SOURCE ILIKOS Consulting Group